Amanote Research
Register
Sign In
RANKL-RANK Signaling Regulates Osteoblast Differentiation and Bone Formation
Bone Research
- United Kingdom
doi 10.1038/s41413-018-0040-9
Full Text
Open PDF
Abstract
Available in
full text
Categories
Endocrinology
Physiology
Histology
Metabolism
Diabetes
Date
November 27, 2018
Authors
Xu Cao
Publisher
Springer Science and Business Media LLC
Related search
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Osthole Stimulates Osteoblast Differentiation and Bone Formation by Activation of Β-Catenin-BMP Signaling
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
International Journal of Medical Sciences
Medicine
Estrogen-Related Receptor Regulates Osteoblast Differentiation via WNT/ -Catenin Signaling
Journal of Molecular Endocrinology
Endocrinology
Molecular Biology
RANKL–RANK Signaling Regulates Expression of Xenotropic and Polytropic Virus Receptor (XPR1) in Osteoclasts
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Lhx2 Regulates Bone Remodeling in Mice by Modulating RANKL Signaling in Osteoclasts
Cell Death and Differentiation
Cell Biology
Molecular Biology
Peroxiredoxin II Negatively Regulates BMP2-induced Osteoblast Differentiation and Bone Formation via PP2A Cα-Mediated Smad1/5/9 Dephosphorylation
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Ras Signaling Regulates Osteoprogenitor Cell Proliferation and Bone Formation
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine